Full-Time

Senior Manager

Strategic Marketing

Fortive

Fortive

5,001-10,000 employees

Global industrial tech company for safety

No salary listed

Remote in USA

Remote

Category
Growth & Marketing (1)
Required Skills
Market Research
Marketing
Requirements
  • Bachelor’s Degree required; Master’s degree preferred
  • 5-8 years relevant experience, with 3-5 years in leadership roles
  • Experience working in healthcare, SaaS organizations is preferred
  • Excellent written and verbal communication skills
  • Ability to travel 25% travel required
Responsibilities
  • Lead ongoing market, customer, and competitive analysis within the Hospital & ASC anesthesia ecosystem to identify trends, unmet needs, workflow gaps, technology maturity, and emerging buying behaviors.
  • Build a comprehensive segmentation framework that incorporates Hospital & ASC characteristics such as specialty mix, ownership model, anesthesia staffing structure (employed vs. contracted groups), payer mix, volume growth potential, and EHR/AIMS environment.
  • Define and continuously refine ICPs and priority segments, ensuring clear rationale for where the company should focus investment and why.
  • Develop a long-term category point of view that positions the organization as a leader in anesthesia operations, documentation, and revenue cycle optimization—driving internal alignment and external differentiation.
  • Produce market insights that shape product strategy, commercial motions, investment decisions, and executive direction.
  • Design strategic demand generation programs that address role-specific needs across the Hospital & ASC buying committee, delivering tailored messaging for administrators, anesthesia group leaders, clinical directors, and IT stakeholders.
  • Build campaign architectures tied to market trends (e.g., shift of ortho/GI cases to ASC, revenue cycle pressures, staffing challenges), ensuring relevance and high engagement.
  • Own funnel performance with a strategic lens, ensuring investment decisions align with growth priorities, pipeline coverage needs, and segment-level opportunity.
  • Continuously evaluate and optimize channel mix, offer strategy, and campaign sequencing based on insights into buyer behavior, clinical pain points, and market maturity.
  • Build and manage comprehensive product launch and GTM plans for new product releases or enhancements, including sales enablement, market readiness, pricing, competitive rationale, launch sequencing, and feedback loops to measure success.
  • Develop differentiated, strategic positioning and messaging rooted in clinical, operational, and financial value—clearly articulating how anesthesia technology impacts throughput, documentation quality, cash acceleration, and compliance.
  • Own the messaging architecture for new categories, product lines, and solution bundles, ensuring consistent storytelling across all marketing and sales channels.
  • Partner with Product and Finance to build data-driven pricing and packaging strategies that align with Hospital & ASC economic models (per-case, per-OR, specialty-based, or volume-tiered approaches).
  • Ensure every GTM motion reinforces the company's position as a strategic partner to Hospitals & ASCs and anesthesia groups—not just a software vendor.
  • Deliver strategic sales enablement materials that equip teams to position value, articulate differentiation, and navigate complex Hospital & ASC buying cycles.
  • Lead cross-functional VOC programs (interviews, advisory councils, post-implementation insights) to capture deep customer understanding and turn findings into actionable inputs for Product, Sales, and Executive teams.
  • Translate market shifts, competitive moves, and buyer sentiment into strategic recommendations for commercial leadership.
  • Serve as a key connector across Product, Customer Success, Sales, and Finance to ensure coherent messaging, consistent customer experience, and aligned growth priorities.
  • Champion strategic alignment across the organization, ensuring GTM, roadmap, and revenue motions are integrated and grounded in market reality.
  • Connect product capabilities to measurable ASC financial and clinical outcomes—such as improved documentation accuracy, reduced denials, faster days-to-bill, and increased OR throughput—to strengthen buyer confidence.
  • Build strategic dashboards and insights reports that inform where future investments should go (segments, features, campaigns, personas).
  • Evaluate campaign, messaging, and GTM effectiveness using both quantitative metrics and qualitative customer feedback, recommending strategic shifts as needed.
  • Develop clear, repeatable ROI models, outcomes-based narratives, and case studies that elevate the company’s credibility and accelerate deal velocity.
  • Act as a strategic advisor to Sales and leadership by translating market performance into actionable recommendations for focus, investment, and positioning.

Fortive is a global industrial technology company that provides essential tools and systems in key safety and productivity sectors, including healthcare sterilization, industrial safety, predictive maintenance, and building environments. Its products combine hardware, software, and services to help customers improve safety, efficiency, and patient care. The company operates with a startup spirit at scale, guided by the Fortive Business System (FBS) to accelerate continuous improvement and positive impact. Fortive differentiates itself through its emphasis on mission-critical, field-ready solutions and a culture of collaboration, learning, and growth across about 10,000 employees worldwide. Its goal is to solve large-scale problems for customers and partners around the world, making workplaces safer, facilities more reliable, and healthcare providers more focused on patient care.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Washington DC, District of Columbia

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 core revenue grew 5% with 29.3% EBITDA margin.
  • $1.1B and $1.5B bonds maintain 2.8x debt-to-EBITDA flexibility.
  • Tariffs diminish by Q3 2026, unlocking margin expansion.

What critics are saying

  • Regal Rexnord's 2022 Altra acquisition erodes motion control pricing.
  • Tariffs compress gross margins 100-150 bps through Q3 2026.
  • Precision spin-off strips $1.1B revenue, exposes to cycles.

What makes Fortive unique

  • Fluke instruments specified in 1/3 of data center operations protocols.
  • SmartTrace 2082 integrates with PointMan for recurring software revenue.
  • AI-enabled launches target gas-detection and data center demand.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Fortive who can refer or advise you

Benefits

Remote Work Options

Professional Development Budget

Company News

Yahoo Finance
Mar 21st, 2026
Fortive's SmartTrace 2082 Series integrates with PointMan for digital underground asset mapping

Fortive subsidiary Fluke Corporation has launched the SmartTrace 2082 Series Underground Locators, which integrates with ProStar's PointMan platform for real-time digital documentation of underground utilities and assets. The product aims to improve field accuracy, safety and infrastructure protection. The launch reinforces Fortive's strategy towards higher recurring revenue and software-enhanced tools following its Precision Technologies spin-off. SmartTrace's connected infrastructure mapping aligns with the company's focus on digital workflows and recurring software services, which analysts view as central to improving revenue visibility and margins. However, the product does not materially change near-term catalysts or key risks, including public-sector spending softness, tariff exposure and M&A execution challenges. Fortive's narrative projects $4.5 billion revenue and $741.9 million earnings by 2028.

Yahoo Finance
Mar 13th, 2026
Fortive stock falls 25.7% in 52 weeks, trailing PAVE's 33.1% gain amid tariff concerns

Fortive Corporation, a global industrial technology company specialising in automation and measurement tools, has underperformed compared to broader infrastructure stocks. With a market capitalisation of $17.34 billion, Fortive's shares have declined 25.7% over the past 52 weeks, whilst the Global X US Infrastructure Development ETF has gained 33.1% over the same period. The stock is currently trading near its 200-day moving average after falling below its 50-day moving average in mid-March. However, shares rose 10.6% intraday on 4th February following better-than-expected Q4 results, with revenue increasing 4.6% year-over-year to $1.12 billion and adjusted EPS rising 12.5% to $0.90. Analysts project fiscal 2026 EPS to grow 8.9% annually to $2.95. The company remains focused on its "Accelerated" strategy targeting profitable organic growth.

Yahoo Finance
Feb 4th, 2026
Fortive stock jumps 9.6% on Q4 earnings beat and optimistic 2026 guidance

Fortive shares surged 9.6% after the industrial technology company reported fourth-quarter earnings and revenue that exceeded analyst expectations and provided optimistic guidance for 2026. The company posted adjusted earnings of $0.90 per share, beating the anticipated $0.84, whilst revenue reached $1.12 billion, up 4.6% year-over-year. Fortive forecast full-year 2026 adjusted earnings between $2.90 and $3.00 per share, notably above the analyst consensus of $2.84. The projection signals management confidence in future performance. Despite the recent gain, Fortive shares remain 28.4% below their 52-week high of $82.98 from February 2025, though they are up 7.3% year-to-date. The stock has shown relatively low volatility, with only five moves greater than 5% over the past year.

Yahoo Finance
Feb 4th, 2026
Fortive forecasts annual profit above estimates on strong industrial automation demand

Fortive has forecast annual profit above Wall Street estimates, driven by resilient demand in its industrial automation business. The Everett, Washington-based company expects adjusted earnings of $2.90 to $3 per share for fiscal 2026, surpassing analysts' average estimate of $2.84 per share. The industrial products maker's shares rose 3% in premarket trading. Revenue at its intelligent operating solutions segment, which produces industrial measurement equipment and software-enabled automation, grew 5.3% in the fourth quarter year-on-year. For the quarter ended 31 December, Fortive reported adjusted profit of 90 cents per share, beating expectations of 84 cents. Quarterly sales increased 4.6% to $1.12 billion. The company has benefited from businesses investing heavily in optimising industrial operations.

Business Wire
Feb 4th, 2026
Fortive reports Q4 2025 results with 3% core revenue growth, deploys $1.6B in share buybacks

Fortive has reported fourth quarter 2025 results with revenue of $1.12 billion, up 4.6% year-over-year, and 3.3% core revenue growth. Adjusted EBITDA rose 7.8% to $358 million, whilst adjusted diluted earnings per share increased 12.5% to $0.90, exceeding full-year guidance. For the full year 2025, Fortive posted revenue of $4.16 billion, up 1.9%, with adjusted EBITDA of $1.23 billion. The company deployed $1.6 billion towards share repurchases during the year, including $265 million in the fourth quarter alone. CEO Olumide Soroye said the results demonstrate solid execution of the company's Fortive Accelerated strategy. The company has initiated 2026 guidance of $2.90 to $3.00 adjusted earnings per share. Fortive completed separation of its Precision Technologies segment in June 2025.